The $6 Billion Shot at Making New Antibiotics—Before the Old Ones Fail
Antimicrobials cost as much to develop as other drugs, but don’t earn the same returns. Congress could give drugmakers a boost, but time is running out.Thanks for listening to WIRED. Check back in tomorrow to hear more stories from WIRED.com. Learn more about your ad choices. Visit podcastchoices.com/adchoices
What's New · SpokenLayer
November 15, 202210m 49s
Audio is streamed directly from the publisher (dovetail.prxu.org) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Antimicrobials cost as much to develop as other drugs, but don’t earn the same returns. Congress could give drugmakers a boost, but time is running out.Thanks for listening to WIRED. Check back in tomorrow to hear more stories from WIRED.com.
Learn about your ad choices: dovetail.prx.org/ad-choices